The FY23 Defense Appropriations Act is anticipated to provide funding for the BCRP to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for service members, veterans, and the general public.
The V Foundation has established a grant program aimed at increasing female representation and female-led innovation in cancer research.
The FY23 Defense Appropriations Act provides funding for the Ovarian Cancer Research Program to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.
FDA’s Oncology Center of Excellence published a Request for Applications for projects focused on applied regulatory science research to understand factors that affect the safety and efficacy of underrepresented populations in oncology therapeutic development.
FDA’s Oncology Center of Excellence published a Request for Applications for projects aimed at developing and implementing new approaches to support drug development for ultra-rare pediatric and adult cancers.
Fight Colorectal Cancer is committing $150,000 per year for a three-year research fellowship to study clinical data at Tempus, an artificial intelligence and precision medicine company.
Friends and colleagues of Theresa Mays have established the Theresa Mays Endowed Merit Award to promote the education and advancement of oncology research for pharmacists.
Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine issued a call for proposals for the 2023 Harrington-Medical Scientist Training Program Scholar Award to help the next generation of physician-scientists advance their discoveries towards clinical application.
Thermo Fisher Scientific is accepting submissions for the fifth round of the Oncomine Clinical Research Grant program.
DoD Peer Reviewed Cancer Research Program anticipated funding opportunities for the 2022 fiscal year
The Department of Defense Peer Reviewed Cancer Research Program anticipates several funding opportunities for FY22.